AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Pfizer Ltd. Capital/Financing Update 2023

Nov 1, 2023

60507_rns_2023-11-01_b0674f47-9685-44bc-81bb-6739f9562b16.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

November 1, 2023

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Agreement to Assign and Assume the Lease of MIDC Land and Sale of Building constructed on such Land for transferring and assigning Pfizer’s unexpired leasehold rights in the land situated at Plot No. 16, Trans Thane Creek Industrial Area, Turbhe, Thane to Zoetis Pharmaceutical Research Private Limited.

Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“LODR Regulations”), we wish to inform you that, pursuant to the approval of Board of Directors of the Company dated November 1, 2023, the Company has entered into an Agreement to Assign and Assume the Lease of MIDC Land and Sale of Building constructed on such land for transferring and assigning Pfizer’s unexpired leasehold rights in the land admeasuring approx. 82,000 sq. mtrs. situated at Plot No. 16, Trans Thane Creek Industrial Area, Turbhe, Thane (“Land”) and sale of structures and buildings having total built-up area of approx. 16,494.33 sq. mtrs. constructed thereon (“Buildings”), to Zoetis Pharmaceutical Research Private Limited, for a lumpsum consideration of Rs. 264.40 Crores (Rupees Two Hundred Sixty-Four Crores and Forty Lakhs only).

The said transfer of unexpired leasehold rights in the Land and sale of Buildings thereon, shall be subject to requisite approvals from concerned regulatory authorities, including the Maharashtra Industrial Development Corporation.